Table 1 Patient profiles
Control group (n = 46) | HF group (n = 15) | Pearson's chi squares test | ||
|---|---|---|---|---|
n (%) | n (%) | P value | ||
Sex | Female | 21 (46) | 5 (33) | |
Male | 25 (54) | 10 (67) | 0.44 | |
Mann-Whitney U test | ||||
Scores | PRISM III | 37 (14 to 90) | 35 (17 to 51) | 0.29 |
PELOD | 628(492 to 694) | 633 (551 to 651) | 0.93 | |
OI | 20 (1 to 30) | 20 (10 to 20) | 0.82 | |
AaDO2 | 25 (14 to 39) | 20 (14 to 40) | 0.18 | |
Pearson's chi squared test | ||||
Start ECMO | Oct 2002 to Aug 2004 | 38 (83) | 0(0) | |
Aug 2004 to July 2006 | 8 (17) | 15 (100) | - | |
Diagnosis | CDH | 16 (35) | 3 (20) | |
MAS* | 16 (35) | 5 (33) | ||
Respiratory diseases | 7 (15) | 2(13) | ||
Sepsis | 4 (9) | 2 (14) | ||
Idiopathic PPHN | 2 (4) | 2 (13) | ||
Post-cardiac surgery | 1 (2) | 1 (7) | 0.73 | |
Surgery | No surgery | 42(91) | 12 (80) | |
CDH closure | 3 (7) | 2 (13) | ||
Great vessel surgery | 1 (2) | 1 (7) | 0.24 | |
ECMO mode | Veno-arterial | 44 (96) | 13 (87) | |
Veno-venous | 2 (4) | 2 (13) | 0.22 | |
median (min to max) | median (min to max) | |||
Body weight (kg) | 3.3 (1.9 to 5) | 3.5 (2.5 to 5) | 0.31 | |
Age (days) | 1.7 (0.5 to 18) | 2.2 (0.9 to 6.7) | 0.28 |